Skip to search formSkip to main contentSkip to account menu

Milrinone Lactate

Known as: Lactate, Milrinone, Milrinone Lactate [Chemical/Ingredient] 
A bipyridine agent with positive inotropic and vasodilator properties. Milrinone lactate selectively inhibits fraction III cyclic adenosine… 
National Institutes of Health

Related topics

Related topics

8 relations
100 ML Milrinone Lactate 0.2 MG/ML InjectionCongestive heart failureDrug toxicityHypersensitivity

Broader (1)

Milrinone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Milrinone Pharmacokinetics and Pharmacodynamics in Neonates with Persistent Pulmonary Hypertension of the Newborn
Objective To describe the pharmacokinetics and pharmacodynamics of milrinone in infants with persistent pulmonary hypertension of… 
2007
2007
Method of preparing milrinone lactate
The invention discloses a preparation method of lactate milrinone, which belongs to the fields of chemicals and chemical… 
2002
2002
Physical compatibility of milrinone lactate injection with intravenous drugs commonly used in the pediatric intensive care unit.
1999
1999
Stability of milrinone lactate in the presence of 29 critical care drugs and 4 i.v. solutions.
The stability of milrinone lactate in the presence of 29 critical care drugs during simulated Y-site injection and in 4 i.v… 
1999
1999
Assessment of inotropic and vasodilating effects of milrinone lactate in patients with dilated cardiomyopathy and severe heart failure.
OBJECTIVE To assess the hemodynamic and vasodilating effects of milrinone lactate (ML) in patients with dilated cardiomyopathy… 
Highly Cited
1998
Highly Cited
1998
Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock.
1998
1998
Stability of Milrinone Lactate 200 mcg/mL in 5% Dextrose Injection and 0.9% Sodium Chloride Injection
The stability of milrinone lactate 200 microgram/mL in either 5% dextrose injection or 0.9% sodium chloride injection was studied… 
1998
1998
Stability of Milrinone Lactate in 5% Dextrose Injection and 0.9% Sodium Chloride Injection at Concentrations of 400, 600, 800 mcg/mL
Milirone lactate is a phosphodiesterase inhibitor that is used in the acute phase of congestive heart failure. It is available in… 
Highly Cited
1996
Highly Cited
1996
Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study.
STUDY OBJECTIVE To determine the hemodynamic effects of i.v. milrinone lactate in pediatric patients with nonhyperdynamic septic… 
1996
1996
PHARMACOKINETICS AND PHARMACODYNAMICS OF MILRINONE LACTATE IN PEDIATRIC PATIENTS WITH SEPTIC SHOCK. † 288
PHARMACOKINETICS AND PHARMACODYNAMICS OF MILRINONE LACTATE IN PEDIATRIC PATIENTS WITH SEPTIC SHOCK. † 288 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)